Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Distal Airway Dysbiosis Present in Early RA
Microbiome; ePub 2016 Nov 17; Scher, et al
Distal airway dysbiosis is present in untreated early rheumatoid arthritis (RA) and similar to that detected in sarcoidosis lung inflammation, according to a recent study. This community perturbation, which correlates with local and systemic autoimmune/inflammatory changes, may potentially drive initiation of RA in a proportion of cases. Researchers utilized 16S rRNA gene high-throughput sequencing to compare the bacterial community composition of bronchoalveolar lavage fluid (BAL) in patients with early, disease-modifying anti-rheumatic drugs (DMARD)-naïve RA, patients with lung sarcoidosis, and healthy control subjects. Samples were further assessed for the presence and levels of anti-citrullinated peptide antibodies (including fine specificities) in both BAL and serum. They found:
- The BAL microbiota of RA patients was significantly less diverse and abundant when compared to healthy controls, but similar to sarcoidosis patients.
- This distal airway dysbiosis was attributed to the reduced presence of several genus (ie, Actynomyces and Burkhordelia) as well as reported periodontopathic taxa, including Treponema, Prevotella, and Porphyromonas.
Scher JU, Joshua V, Artacho A, et al. The lung microbiota in early rheumatoid arthritis and autoimmunity. [Published online ahead of print November 17, 2016]. Microbiome. doi:10.1186/s40168-016-0206-x.